Global health sector strategies guide the health sector in implementing strategically focused responses to achieve the goals of ending AIDS, viral hepatitis B and C and sexually transmitted infections by 2030.
/global-hiv-hepatitis-and-stis-programmes-(hhs)/accountability-ghss-design-arrows.png?sfvrsn=284936b7_4 "accountability-ghss-design-arrows")
/global-hiv-hepatitis-and-stis-programmes-(hhs)/nbt-toolkit-banner.png?sfvrsn=e613817f_3 "nbt-toolkit-banner")
/global-hiv-hepatitis-and-stis-programmes-(hhs)/hivst-zimbabwe-afro-nologo-1920.jpg?sfvrsn=a70f3d5b_2 "hivst-zimbabwe-afro-nologo-1920")
/global-hiv-hepatitis-and-stis-programmes-(hhs)/community-testing-in-can-tho-viet-nam.jpg?sfvrsn=6de039d3_5 "community testing in Can Tho Viet Nam")
Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections
The WHO Department leads the global effort to end the epidemics of HIV, tuberculosis (TB), hepatitis, and sexually transmitted infections (STIs), ensuring that every person has equitable access to highest-quality people-centred scientific evidence and services, regardless of who they are or where they live.
Featured
Ending TB is not just a public health problem, but a development challenge and opportunity. WHO’s post-2015 End TB Strategy, adopted by the World Health Assembly in 2014, aims to end the global TB epidemic as part of the newly adopted Sustainable Development Goals.
Publications
All →
30 October 2026
Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance,...
Rapid and accurate detection of drug resistance is essential to ensure that people with tuberculosis (TB) receive appropriate and effective treatment....
26 October 2026
Target regimen profiles for long-acting injectables for tuberculosis prevention and treatment
Long-acting injectables (LAIs) could shift the burden of adherence from people taking tuberculosis (TB) medicines to the health system that delivers them,...
20 October 2026
Guidance on evidence generation on new tuberculosis diagnostics
The Guidance on evidence generation (GEG) for new tuberculosis diagnostics advises researchers, developers, funders and other stakeholders on how evidence...
13 October 2026
Philippines–WHO country cooperation strategy 2025–2028
The Philippines–WHO Country Cooperation Strategy 2025–2028 defines the strategic priorities guiding collaboration between the World Health...
12 October 2026
Funding a tuberculosis-free future: an investment case for screening and preventive treatment, second...
This document presents the findings of a modelling study that examined in detail the costs and benefits of tuberculosis (TB) screening plus TB preventive...
8 October 2026
Universal social protection inclusive of people with tuberculosis: monitoring and evaluation framework
Universal social protection is essential to ending tuberculosis (TB). People with TB often face substantial health-related expenses, loss of income and...
25 September 2026
WHO consolidated guidelines on tuberculosis: module 4: treatment and care, 2nd edition
WHO’s Department for HIV, Tuberculosis, Hepatitis and Sexually Transmitted Infections maintains all current recommendations on tuberculosis (TB)...
The WHO South-East Asia Region remains central to the global fight against tuberculosis (TB). According to the WHO Global Tuberculosis Report 2025 (2024...
/global-hiv-hepatitis-and-stis-programmes-(hhs)/gustavo-distributes-an-hiv-and-other-stis-prevention-kit-in--brazil.jpg?sfvrsn=9222c363_9 "Gustavo distributes an HIV and other STIs prevention kit in Brazil")
